Works matching DE "UVEAL melanoma"
Results: 111
Clinical experience with tebentafusp in metastatic uveal melanoma.
- Published in:
- Oncolog-Hematolog, 2024, v. 69, n. 4, p. 23
- By:
- Publication type:
- Article
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 1, p. 146, doi. 10.3390/biom15010146
- By:
- Publication type:
- Article
Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 5, p. 480, doi. 10.1080/0284186X.2023.2211206
- By:
- Publication type:
- Article
Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study.
- Published in:
- Acta Dermato-Venereologica, 2024, v. 104, p. 1, doi. 10.2340/actadv.v104.41297
- By:
- Publication type:
- Article
Simultaneous choroidal melanoma and renal cell carcinoma in middle-aged patient.
- Published in:
- Ophthalmology Journal (2450-7873), 2023, v. 8, p. 25, doi. 10.5603/OJ.2023.0006
- By:
- Publication type:
- Article
Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1333, doi. 10.3390/jcm14041333
- By:
- Publication type:
- Article
A Review and Comparison of Immune-Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 3, p. 885, doi. 10.3390/jcm14030885
- By:
- Publication type:
- Article
Case Report: Longterm metabolic response of metastatic uveal melanoma to pembrolizumab on FDG-PET/CT despite a serial pseudoprogressions phenomenon.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1243208
- By:
- Publication type:
- Article
Sensitivity of contributing factors to heterogeneity corrections in dosimetry of ocular brachytherapy using iodine-125 COMS plaques.
- Published in:
- Journal of Contemporary Brachytherapy, 2024, v. 16, n. 5, p. 371, doi. 10.5114/jcb.2024.144232
- By:
- Publication type:
- Article
Intraocular Pressure and Cup-to-Disc Ratio Asymmetry in Diagnosing Iris Melanoma.
- Published in:
- Clinical Ophthalmology, 2024, v. 18, p. 2907, doi. 10.2147/OPTH.S440072
- By:
- Publication type:
- Article
Geographic Patterns of Ocular Oncologist Supply and Patient Demand for Uveal Melanoma Treatment in the United States: A Supply and Demand Analysis.
- Published in:
- Clinical Ophthalmology, 2024, v. 18, p. 2487, doi. 10.2147/OPTH.S472064
- By:
- Publication type:
- Article
Pseudomelanomas at a referral ocular oncology center in Brazil.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances.
- Published in:
- Biomedicines, 2025, v. 13, n. 1, p. 108, doi. 10.3390/biomedicines13010108
- By:
- Publication type:
- Article
Uveal Melanoma: Comprehensive Review of Its Pathophysiology, Diagnosis, Treatment, and Future Perspectives.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1758, doi. 10.3390/biomedicines12081758
- By:
- Publication type:
- Article
The Role of Autophagy in Human Uveal Melanoma and the Development of Potential Disease Biomarkers and Novel Therapeutic Paradigms.
- Published in:
- Biomedicines, 2024, v. 12, n. 2, p. 462, doi. 10.3390/biomedicines12020462
- By:
- Publication type:
- Article
KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/1556485
- By:
- Publication type:
- Article
A New Frontier of Hope: Highlighting the Promising Potential of Spliceosome Inhibitor E7107 in Treating SF3B1 Mutant Uveal Melanoma.
- Published in:
- Pakistan Journal of Ophthalmology, 2025, v. 41, n. 1, p. 114, doi. 10.36351/pjo.v41i1.1996
- By:
- Publication type:
- Article
PREVENTION AND DIAGNOSIS.
- Published in:
- Dermatology Reports, 2024, v. 16, n. 4, p. 6
- Publication type:
- Article
EPIDEMIOLOGY, GENETICS AND PATHOGENESIS.
- Published in:
- Dermatology Reports, 2024, v. 16, n. 4, p. 1
- Publication type:
- Article
Unmet needs in patients with high risk uveal melanoma undergoing liver surveillance.
- Published in:
- Cancer Nursing Practice, 2019, v. 18, n. 4, p. 36, doi. 10.7748/cnp.2019.e1582
- By:
- Publication type:
- Article
Multifunctional Thermoelectric Nanocatalysts for Synergistic Uveal Melanoma Treatment by Specific Cuproptosis and Pyroptosis.
- Published in:
- Advanced Functional Materials, 2025, v. 35, n. 8, p. 1, doi. 10.1002/adfm.202415688
- By:
- Publication type:
- Article
Enhancement of the Anticancer Effect during the Simultaneous Treatment of Cells by a Cold Atmospheric Plasma Jet and Gold Nanoparticles.
- Published in:
- Plasma Physics Reports, 2024, v. 50, n. 11, p. 1375, doi. 10.1134/S1063780X24601597
- By:
- Publication type:
- Article
White matter: A good reference for the signal intensity evaluation in magnetic resonance imaging for the diagnosis of uveal melanoma.
- Published in:
- Neuroradiology Journal, 2021, v. 34, n. 2, p. 113, doi. 10.1177/1971400920973407
- By:
- Publication type:
- Article
Machine learning and single-cell RNA sequencing reveal relationship between intratumor CD8<sup>+</sup> T cells and uveal melanoma metastasis.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03539-3
- By:
- Publication type:
- Article
Hypoxia-related lncRNA correlates with prognosis and immune microenvironment in uveal melanoma.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03509-9
- By:
- Publication type:
- Article
Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Enhanced differentiation of uveal melanoma and benign sinonasal lesion using [<sup>18</sup>F]AlF-NOTA-PRGD2 PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 3, p. 1223, doi. 10.1007/s00259-024-06983-5
- By:
- Publication type:
- Article
Frequency of HLA-A*02:01 in the Brazilian population and its impact on uveal melanoma systemic treatment.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. e1098, doi. 10.1093/oncolo/oyae112
- By:
- Publication type:
- Article
Continuing Professional Development.
- Published in:
- Clinical & Experimental Ophthalmology, 2024, v. 52, n. 9, p. 1028, doi. 10.1111/ceo.14463
- Publication type:
- Article
The Current State of Systemic Therapy of Metastatic Uveal Melanoma.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 5, p. 691, doi. 10.1007/s40257-024-00872-1
- By:
- Publication type:
- Article
Characterizations of uveal melanoma patients with three additional primary malignancies.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, n. 6, p. 690, doi. 10.1111/aos.16631
- By:
- Publication type:
- Article
Ruthenium brachytherapie and sandwich therapy for medium sized uveal melanomas.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
A cohort of long-surviving patients affected by small and medium uveal melanoma treated with ruthenium-106 plaque brachytherapy.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2024, v. 28, n. 4, p. 318, doi. 10.5114/wo.2024.146992
- By:
- Publication type:
- Article
Beyond benign: ventricular ectopy as a clue to cardiac metastasis in melanoma.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
FDA Approves Melphalan as a Liver-Directed Treatment for Uveal Melanoma.
- Published in:
- ONS Voice, 2023, p. 1
- Publication type:
- Article
Oncology Drug Reference Sheet: Tebentafusp-Tebn.
- Published in:
- ONS Voice, 2022, p. 3
- By:
- Publication type:
- Article
Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients.
- Published in:
- Journal of Behavioral Medicine, 2022, v. 45, n. 1, p. 115, doi. 10.1007/s10865-021-00252-8
- By:
- Publication type:
- Article
A prospective study of cancer-related benefit finding in uveal melanoma patients.
- Published in:
- Journal of Behavioral Medicine, 2021, v. 44, n. 1, p. 131, doi. 10.1007/s10865-020-00175-w
- By:
- Publication type:
- Article
'I Don't Like Uncertainty, I Like to Know': How and why uveal melanoma patients consent to life expectancy prognostication.
- Published in:
- Health Expectations, 2022, v. 25, n. 4, p. 1498, doi. 10.1111/hex.13490
- By:
- Publication type:
- Article
Being the Difference.
- Published in:
- Narrative Inquiry in Bioethics, 2024, v. 14, n. 2, p. 70, doi. 10.1353/nib.2024.a945331
- By:
- Publication type:
- Article
Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas.
- Published in:
- Radiation Oncology, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13014-024-02576-6
- By:
- Publication type:
- Article
Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas.
- Published in:
- Radiation Oncology, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13014-024-02576-6
- By:
- Publication type:
- Article
Efficacy and safety of proton radiotherapy in treating choroidal melanoma: a systematic review and meta-analysis.
- Published in:
- Radiation Oncology, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13014-024-02580-w
- By:
- Publication type:
- Article
Single-cell and bulk transcriptome analysis reveals tumor cell heterogeneity and underlying molecular program in uveal melanoma.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05831-2
- By:
- Publication type:
- Article
Single-cell hdWGCNA reveals metastatic protective macrophages and development of deep learning model in uveal melanoma.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05421-2
- By:
- Publication type:
- Article
Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 18, p. 16691, doi. 10.1007/s00432-023-05401-x
- By:
- Publication type:
- Article
Insights into ocular cancer oncogenesis (Review).
- Published in:
- World Academy of Sciences Journal, 2025, v. 7, n. 2, p. N.PAG, doi. 10.3892/wasj.2024.307
- By:
- Publication type:
- Article
Cell-mediated and humoral immunity of choroidal melanoma patients after treatment with photocoagulation combined with strontium-90/yttrium-90 therapy versus transpupillary thermotherapy combined with strontium-90/yttrium-90 therapy.
- Published in:
- Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2025, n. 1, p. 34, doi. 10.31288/oftalmolzh202513440
- By:
- Publication type:
- Article
Complications after proton therapy of choroidal melanoma: A case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1555842
- By:
- Publication type:
- Article